Kits Eyecare Ltd. (KTYCF)
USD 6.0
(-0.83%)
USD 6.0
(-0.83%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 2.4 Million | 4.67 Million | -19.46 Million | 4.18 Million | 4.14 Million |
| Net Income | -2.21 Million | -4.55 Million | -14.61 Million | -6.58 Million | 53 Thousand |
| Depreciation & Amortization | 3.18 Million | 3.52 Million | 2.67 Million | 2.01 Million | 1.32 Million |
| Deferred income taxes | -676 Thousand | -1.32 Million | -4.22 Million | -505 Thousand | 37 Thousand |
| Stock-based compensation | 513 Thousand | 1.31 Million | 1.51 Million | 811 Thousand | 130 Thousand |
| Change in working capital | 343 Thousand | 4.06 Million | -6.77 Million | 1.72 Million | 965 Thousand |
| Other non-cash items | 1.25 Million | 1.64 Million | 1.96 Million | 6.72 Million | 1.63 Million |
| Investing Cash Flow | -563 Thousand | -258 Thousand | -3.63 Million | -225 Thousand | -29.26 Million |
| Investments in PPE | -563 Thousand | -258 Thousand | -3.63 Million | -225 Thousand | -993 Thousand |
| Acquisitions | - | - | - | - | -28.27 Million |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | - | - | - | -34 Thousand | -673 Thousand |
| Financing Cash Flow | -5.07 Million | -5.12 Million | 41.47 Million | -4.83 Million | 28.61 Million |
| Debt repayment | -4.06 Million | -5.12 Million | -9.88 Million | -4.83 Million | -1.54 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 65 Thousand | - | 55 Million | - | 7 Million |
| Other Financing Activities | -1.07 Million | - | -3.64 Million | - | 23.16 Million |
| Accounts receivables | -897 Thousand | -457 Thousand | 669 Thousand | -205 Thousand | -490 Thousand |
| Accounts payables | -845 Thousand | 6.49 Million | -41 Thousand | 4.48 Million | 2.4 Million |
| Inventory | 1 Million | -2.92 Million | -7.68 Million | -2.96 Million | -1.3 Million |
| Other working capital | 1.08 Million | 961 Thousand | 278 Thousand | 417 Thousand | 352 Thousand |
| Cash at beginning of period | 18.79 Million | 20.5 Million | 2.3 Million | 3.39 Million | - |
| Cash at end of period | 16.04 Million | 18.79 Million | 20.5 Million | 2.3 Million | 3.39 Million |
| Capital Expenditure | -563 Thousand | -258 Thousand | -3.63 Million | -225 Thousand | -993 Thousand |
| Effect of forex changes on cash | 480 Thousand | -1 Million | -187 Thousand | -209 Thousand | -98 Thousand |
| Net cash flow / Change in cash | -2.75 Million | -1.71 Million | 18.19 Million | -1.09 Million | 3.39 Million |
| Free Cash Flow | 1.84 Million | 4.41 Million | -23.09 Million | 3.95 Million | 3.15 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 187 Thousand | 64 Thousand | -491 Thousand | -2.21 Million | 480 Thousand | -1.18 Million |
| Depreciation & Amortization | 592 Thousand | 754 Thousand | 793 Thousand | 3.18 Million | 776 Thousand | 754 Thousand |
| Deferred income taxes | 124 Thousand | 18 Thousand | -208 Thousand | -676 Thousand | 72 Thousand | -266 Thousand |
| Stock-based compensation | 539 Thousand | 270 Thousand | 119 Thousand | 513 Thousand | -118 Thousand | 204 Thousand |
| Change in working capital | 1.11 Million | 2.83 Million | -2.58 Million | 343 Thousand | -229 Thousand | 1.37 Million |
| Other non-cash items | 812 Thousand | -807 Thousand | 32 Thousand | 1.25 Million | 272 Thousand | 585 Thousand |
| Investing Cash Flow | -512 Thousand | -26 Thousand | -164 Thousand | -563 Thousand | -110 Thousand | -283 Thousand |
| Investments in PPE | -512 Thousand | -26 Thousand | -164 Thousand | -563 Thousand | -110 Thousand | -283 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -1.23 Million | -1.24 Million | -1.2 Million | -5.07 Million | -1.26 Million | -1.35 Million |
| Debt repayment | -939 Thousand | -961 Thousand | -3.07 Million | -4.06 Million | -1.28 Million | -1.35 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 43 Thousand | 65 Thousand | 22 Thousand | - |
| Other Financing Activities | - | - | 1.82 Million | -1.07 Million | 22 Thousand | - |
| Accounts receivables | -198 Thousand | 268 Thousand | -791 Thousand | -897 Thousand | -180 Thousand | -111 Thousand |
| Accounts payables | 2.09 Million | 2.75 Million | -1.77 Million | -845 Thousand | 330 Thousand | 1.51 Million |
| Inventory | -668 Thousand | -248 Thousand | 14 Thousand | 1 Million | -998 Thousand | 58 Thousand |
| Other working capital | -117 Thousand | 55 Thousand | -28 Thousand | 1.08 Million | 619 Thousand | -86 Thousand |
| Cash at beginning of period | 18.39 Million | 16.04 Million | 19.29 Million | 18.79 Million | 19.82 Million | 19.57 Million |
| Cash at end of period | 19.31 Million | 18.39 Million | 16.04 Million | 16.04 Million | 19.29 Million | 19.82 Million |
| Capital Expenditure | -512 Thousand | -26 Thousand | -164 Thousand | -563 Thousand | -110 Thousand | -283 Thousand |
| Effect of forex changes on cash | -209 Thousand | -504 Thousand | 450 Thousand | 480 Thousand | -409 Thousand | 421 Thousand |
| Net cash flow / Change in cash | 916 Thousand | 2.35 Million | -3.25 Million | -2.75 Million | -527 Thousand | 251 Thousand |
| Free Cash Flow | 2.36 Million | 4.1 Million | -2.5 Million | 1.84 Million | 1.14 Million | 1.18 Million |
0J86
002750
MGAAF
SUVIDHAA
CLS
JYOTHYLAB